Mr. James Lee reports

HEALWELL AI APPOINTS BRAD PORTER TO BOARD OF DIRECTORS

Healwell AI Inc. has appointed Brad Porter to its board of directors, effective immediately.

Mr. Porter, chief commercial officer of Healwell and chief executive officer of Orion Health, brings over 15 years of experience in finance, commercial leadership and global health care technology. A chartered accountant by training, he has held senior commercial roles at Fisher & Paykel Healthcare and has led Orion Health as CEO, driving innovation in health data platforms and AI-enabled (artificial intelligence) care. At Healwell, he oversees group-wide commercial strategy, revenue growth and go-to-market alignment, with a focus on public-sector opportunities and government contracts.

Ian McCrae has decided to step down from Healwell's board of directors to focus on other ventures following the successful integration of Orion Health into Healwell. Mr. McCrae is the founder of Orion Health and built the company over more than three decades into a global leader in health information technology, operating across 12 countries. During his time on the board, he provided valuable guidance on strategic initiatives and played an important role in supporting Healwell through a critical period of integration and growth. Healwell sincerely thanks Mr. McCrae for his dedication, insight and contributions and wishes him continued success.

"We are pleased to welcome Brad Porter to Healwell's board of directors," said Hamed Shahbazi, chair of Healwell AI. "Brad brings deep commercial expertise and global health care experience from his leadership roles at Orion Health and Healwell, and his appointment will further strengthen our ability to execute on our growth strategy.

"We also want to extend our sincere thanks to Ian McCrae for his dedicated service on Healwell's board. His guidance, insight and contributions have been invaluable during a transformative period for the company, and we wish him all the best in his future endeavours."

About Healwell AI Inc.

Healwell is a health care artificial intelligence company focused on preventive care. Its mission is to improve health care and save lives through early identification and detection of disease. Using its own proprietary technology, the company is developing and commercializing advanced clinical decision support systems that can help health care providers detect rare and chronic diseases, improve efficiency of their practice, and ultimately help improve patient health outcomes. Healwell is executing a strategy centred around developing and acquiring technology and clinical sciences capabilities that complement the company's road map. Healwell is publicly traded on the Toronto Stock Exchange under the symbol AIDX and on the OTC (over-the-counter) exchange under the symbol HWAIF.